Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49
A Randomized Controlled Trial on Shared Decision-Making for Colorectal Cancer Screening Among High-Risk First-Degree Relatives Aged 40-49
1 other identifier
interventional
2,286
1 country
1
Brief Summary
The primary objective of this study was to evaluate the impact of a constructed shared decision (SDM) intervention (offering an option between colonoscopy and immunochemical collapsible occult blood testing (fecal immunochemical test; FIT)) on improving the incidence of high colonoscopy stromal in patients aged 40-49 years with a close relative suffering from colorectal cancer, compared to standard care (direct referral for colonoscopy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 31, 2026
November 1, 2025
1.3 years
March 10, 2026
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Colonoscopy screening rate
Completion of colonoscopy within 3 months after randomization, defined as documented completion of colonoscopy or colonoscopy performed after a positive FIT result.
Within 3 months after randomization
Secondary Outcomes (3)
Patient satisfaction with shared decision-making
Immediately after the SDM consultation visit
Participant choice of screening modality (colonoscopy vs fecal immunochemical test)
Immediately after the intervention
Detection rate of colorectal neoplasia
During colonoscopy procedure
Study Arms (2)
Shared Decision-Making
EXPERIMENTALShared Decision-Making
Colonoscopy
ACTIVE COMPARATORColonoscopy
Interventions
Participants underwent standard colonoscopy performed by experienced endoscopists following routine clinical procedures.
Participants received a shared decision-making intervention including educational materials and discussion with clinicians to choose between screening options.
Eligibility Criteria
You may qualify if:
- Age 40 to 49 years at the time of recruitment.
- At least one immediate family member (biological parent, sibling, or child) has been pathologically diagnosed with colorectal cancer.
- Able to read, understand, and provide prior consent.
- Willing to be randomly assigned to any research group and complete all research procedures.
You may not qualify if:
- A personal history of colorectal cancer or inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- Presence of warning signs of colorectal cancer requiring diagnostic evaluation rather than screening (e.g., unexplained rectal bleeding, significant involuntary weight loss, persistent changes in bowel habits).
- Presence of comorbidities that may contraindicate colonoscopy.
- Having undergone colonoscopy within the past three years.
- Inability to read, understand, and provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 10, 2026
First Posted
March 31, 2026
Study Start
September 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 31, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share